Raul Rodriguez
Chief Executive Officer bei RIGEL PHARMACEUTICALS, INC.
Vermögen: 3 Mio $ am 31.03.2024
Profil
Raul R.
Rodriguez is currently the President, Chief Executive Officer & Director at Rigel Pharmaceuticals, Inc. He previously worked as the Executive Director-Business Development at Scios, Inc. from 1994 to 1997, and as the Senior VP-Business Development & Operations at Ontogeny, Inc. from 1997 to 2000.
Mr. Rodriguez holds a graduate degree from the University of Illinois, an MBA from Stanford Graduate School of Business, and an undergraduate degree from Harvard College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.02.2024 | 2 036 629 ( 1,16% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von Raul Rodriguez
| Unternehmen | Position | Beginn |
|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Chief Executive Officer | 21.11.2014 |
Ehemalige bekannte Positionen von Raul Rodriguez
| Unternehmen | Position | Ende |
|---|---|---|
Ontogeny, Inc.
 Ontogeny, Inc. BiotechnologyHealth Technology Ontogeny, Inc., located in Cambridge, Massachusetts whose mission is to become the preeminent biopharmaceutical company focused on translating developmental biology insights into regenerative medicine therapies that will significantly improve the quality of life by activating the body's ability to repair and regenerate, or to specifically control abnormal and malignant growth. The Company is developing therapeutics for neurological diseases including Parkinson's and Alzheimer's diseases, diabetes and dermatological disorders including skin cancer and hair growth. | Chief Operating Officer | 01.03.2000 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Corporate Officer/Principal | 01.03.1997 |
Ausbildung von Raul Rodriguez
| University of Illinois | Graduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
| Harvard College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
Ontogeny, Inc.
Ontogeny, Inc. BiotechnologyHealth Technology Ontogeny, Inc., located in Cambridge, Massachusetts whose mission is to become the preeminent biopharmaceutical company focused on translating developmental biology insights into regenerative medicine therapies that will significantly improve the quality of life by activating the body's ability to repair and regenerate, or to specifically control abnormal and malignant growth. The Company is developing therapeutics for neurological diseases including Parkinson's and Alzheimer's diseases, diabetes and dermatological disorders including skin cancer and hair growth. | Health Technology |
